Study With Bispecific Antibody Engaging T-cells, in Patients With Progressive Cancer Diseases With Positive PSCA Marker

Clinical trial NCT03927573 · TERMINATED

Trial details

NCT number: NCT03927573
Sponsor: AvenCell Europe GmbH
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer Prostate Cancer Renal Cancer Transitional Cell Carcinoma

Start date: 2019-04-15
Primary completion: 2023-06-28
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.